Breast Cancer Behavior Linked to Age

There is a dramatic difference in the way breast cancers behave in women aged above and below 70 years, say Belgium researchers in a first of its kind study, which has linked breast cancer to ageing.

Belgian researchers have made a unique distinction by linking breast cancer to aging. In a study, the researchers say that there is plenty of difference in the behavior of breast tumors in women aged over 70 and those aged below 70.

The researchers claimed that as women get near 70, they become less likely to be diagnosed with aggressive tumours that have spread to the lymph nodes. But after 70, the cancer is increasingly likely to spread, particularly if the tumours are small.

Lead author Professor Hans Wildiers said that he suspects that women older than 70 have decreased immune defence mechanisms, which are less able to deal with tumours that are likely to metastasise to other sites in the body.

"The effect of age of lymph node positivity is not straightforward. There seems to be a different effect between women aged up to 70 years and women older than 70. For the younger group of women, age appears to have a negative effect on lymph node status - the older they become, the less likely the cancer is to have spread to the lymph nodes. For the older group of women (aged over 70), age appears to influence lymph node status in the opposite way - the older they become, the more likely they are to have cancer cells in the lymph nodes if the tumour is small," said Wildiers.

He added: "There is an interaction between age and tumour size, suggesting that, up to the age of 70, age mainly has a positive effect on lymph node status for older women with small tumours. A likely explanation is that breast tumours metastasise less frequently to lymph nodes with increasing age due to the decreased biological aggressiveness in these tumours. On the other hand, over the age of 70, if the tumours have the potential to metastasise to lymph nodes, this occurs more rapidly in smaller tumours and this might be related to decreased immune defence mechanisms in elderly patients."

For the study, the researchers recruited 2,227 women, who had been treated for breast cancer between 2000 and 2006 at the University Hospitals Leuven. Later their results were compared with a separate database of over 11,000 breast cancer patients on the Eindhoven Cancer Registry.

It was discovered that for women aged 70 or younger, increasing age was associated with a decreased prevalence of cancer spreading to the lymph nodes. The women's risk of having positive lymph nodes decreased by 13 percent for every decade they aged, up to age 70.

The results indicated that once aged 70 and over, the odds of lymph node involvement doubled with every 10-year increase in age for women who had tumours that were no bigger than 15mm across. Risk of lymph node involvement continued to decrease if the tumours were larger than 42-43 mm.

"We know that the elderly have depressed immune defences, and, therefore, it is possible that these decreased defences are unable to prevent invasion of the lymph nodes by metastases in a subset of breast tumours in elderly women. Although breast cancer survival in older women appears to be similar to survival in the general population irrespective of disease status, it might well be that there is a balance in the elderly between, on the one hand, a less aggressive type of tumour, and, on the other hand, their decreased immunological defences," said Wildiers.

The findings, he said, supported the idea that there are two types of tumour in elderly women: ones that are slow-growing and don't invade the lymph nodes even if the tumours are larger, and ones that are aggressive and metastasise very early to the lymph nodes.

Women with slow-growing tumours might benefit from less aggressive treatment, while the smaller tumours in the women aged over 70 might need to be treated more aggressively.

"Further research now needs to be conducted into the role the immune system plays in lymph node invasion," Wildiers concluded.

The study was presented at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.

Source-ANI
RAS/L